Anika Therapeutics, Inc. financial data

Symbol
ANIK on Nasdaq
Location
Bedford, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 546% % -1.1%
Quick Ratio 103% % -31%
Return On Equity -22% % 54%
Return On Assets -17% % 55%
Operating Margin -11% % -147%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14,421,219 shares -1.5%
Common Stock, Shares, Outstanding 14,421,000 shares -1.9%
Entity Public Float $373,146,995 USD 0.73%
Common Stock, Value, Issued $144,000 USD -2%
Weighted Average Number of Shares Outstanding, Basic 14,419,000 shares -2.4%
Weighted Average Number of Shares Outstanding, Diluted 14,419,000 shares -2.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $112,806,000 USD 31%
Research and Development Expense $25,825,000 USD 65%
Costs and Expenses $74,156,000 USD 67%
Operating Income (Loss) $12,402,000 USD -161%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $10,032,000 USD -145%
Income Tax Expense (Benefit) $4,234,000 USD -66%
Net Income (Loss) Attributable to Parent $33,037,000 USD 66%
Earnings Per Share, Basic -2 USD/shares 66%
Earnings Per Share, Diluted -2 USD/shares 66%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $57,990,000 USD -7%
Marketable Securities, Current $22,187,000 USD -22%
Accounts Receivable, after Allowance for Credit Loss, Current $22,187,000 USD -22%
Inventory, Net $16,284,000 USD -59%
Assets, Current $101,590,000 USD -25%
Deferred Income Tax Assets, Net $1,251,000 USD -15%
Property, Plant and Equipment, Net $40,684,000 USD -8.7%
Operating Lease, Right-of-Use Asset $24,226,000 USD -11%
Intangible Assets, Net (Excluding Goodwill) $1,650,000 USD -46%
Goodwill $8,051,000 USD 5.2%
Other Assets, Noncurrent $5,507,000 USD -51%
Assets $189,437,000 USD -18%
Accounts Payable, Current $4,732,000 USD -30%
Employee-related Liabilities, Current $8,111,000 USD -23%
Liabilities, Current $19,089,000 USD -25%
Operating Lease, Liability, Noncurrent $22,782,000 USD -9.7%
Other Liabilities, Noncurrent $761,000 USD -5.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,939,000 USD 13%
Retained Earnings (Accumulated Deficit) $60,495,000 USD -35%
Stockholders' Equity Attributable to Parent $146,805,000 USD -18%
Liabilities and Equity $189,437,000 USD -18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $130,000 USD -3.2%
Net Cash Provided by (Used in) Financing Activities $5,438,000 USD -139%
Net Cash Provided by (Used in) Investing Activities $1,672,000 USD
Common Stock, Shares Authorized 90,000,000 shares 0%
Common Stock, Shares, Issued 15,355,000 shares 1.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,788,000 USD 11%
Deferred Tax Assets, Valuation Allowance $45,148,000 USD 228%
Deferred Tax Assets, Gross $59,211,000 USD 97%
Operating Lease, Liability $25,932,000 USD
Depreciation $5,200,000 USD 7.7%
Payments to Acquire Property, Plant, and Equipment $2,824,000 USD 56%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $32,275,000 USD 67%
Property, Plant and Equipment, Gross $91,250,000 USD
Operating Lease, Liability, Current $1,725,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,468,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,783,000 USD -11%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) $18,000 USD -91%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,878,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,329,000 USD -18%
Deferred Tax Assets, Operating Loss Carryforwards $650,000 USD -42%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,250,000 shares 0%
Unrecognized Tax Benefits $600,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,329,000 USD -12%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $600,000 USD -100%
Deferred Tax Assets, Net of Valuation Allowance $14,063,000 USD -14%
Share-based Payment Arrangement, Expense $10,996,000 USD -8.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%